HBSP (USA)
-
Alvogen
Isenberg, Daniel; Kerr, William R.Case HBS-816064-EStrategyAlvogen is a young Icelandic generic pharmaceutical company, whose CEO believes that his global strategy will give them an edge in this competitive industry. Robert Wessman, Alvogen's CEO, was also previously the CEO of Actavis, another Icelandic genericStarting at €8.20